About: The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2006 (uk) article scientifique (publié 2006) (fr) im Jahr 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2006 (ast) artikull shkencor i botuar më 01 janar 2006 (sq) scientific article published on 01 January 2006 (en)
publication date	wds:Q81546299-8943C9A7-ECA4-450B-8634-F96A3F419C3F
publication date	2006-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q81546299-9479DBA1-5EFD-4E88-8124-48EEF4ADEC60
exact match	https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500341
cites work	wds:Q81546299-156CF35B-4971-4DB6-93DB-15FCC047B50F wds:Q81546299-2EF490C6-058C-4B72-B040-A8C99ECE7D54 wds:Q81546299-326ED9D1-5FB1-466A-ACE6-1469ADE94A06 wds:Q81546299-384DAA19-B362-4CBF-830F-6BCEB06EB696 wds:Q81546299-7603A1A1-ABF7-4964-8145-3D3A890F4C33 wds:Q81546299-98951D9D-6543-432E-8C3B-4723DE66777F wds:Q81546299-A9BB1C20-65EC-4BC4-B241-58482F533816 wds:Q81546299-BB31ABA9-9D19-4A31-950E-2F3AFD6717A4 wds:Q81546299-C8298EC2-CBB1-4FD6-8651-EBBD80487586 wds:Q81546299-C8510691-00FB-425A-A130-A217EA87BBB6 wds:Q81546299-DD37B6AE-C79B-4C1D-BC6E-B6D940A8E3F9 wds:Q81546299-EFDF4315-BE59-400F-8607-1E9121653D09
cites work	Pharmacogenomics: bench to bedside Pharmacogenetics and the practice of medicine HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. Pharmacogenetics: potential for individualized drug therapy through genetics Ethical and legal implications of pharmacogenomics Trastuzumab: hopes and realities Assessing the cost-effectiveness of pharmacogenomics Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine Preventing Toxicity With a Gene Test Towards quality assurance and harmonization of genetic testing services in the European Union Pharmacogenomics: out of the lab and into the community Improved HPLC methodology for monitoring thiopurine metabolites in patients on thiopurine therapy
author name string	wds:Q81546299-806E2FA9-DAEE-4B28-9C6E-265430517098 wds:Q81546299-B2ED79C8-9028-4719-B961-3F9FB2843C94 wds:Q81546299-C5FDDCC7-0F22-4A30-A6DD-132546908C40 wds:Q81546299-FA08D081-8F75-47DA-9F7C-5184233D0676
author name string	Rodriguez-Cerezo E Hopkins MM Ibarreta D Woelderink A
rdfs:label	The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (en) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (nl) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (sq)
skos:prefLabel	The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (en) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (nl) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (sq)
name	The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (en) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (nl) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (sq)
title	wds:Q81546299-EEED8965-167F-4C12-9673-414F6D93CDCD
title	The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies (en)
page(s)	wds:Q81546299-3D35B860-B9D9-4E46-95C7-6DE22E4135E7
page(s)	3-7
instance of	wds:Q81546299-1CE5FBD0-8ABE-43C8-8347-9BEB7FB3F984
instance of	scholarly article
PubMed ID	wds:Q81546299-59BA344A-BB2A-48E8-A663-6E8C4C0E9C06
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16314885
PubMed ID	16314885
published in	wds:Q81546299-2DE27635-DD08-4125-9452-63195DAE72A1
published in	The Pharmacogenomics Journal
issue	wds:Q81546299-B8C61616-DE2E-40F9-8410-BA6EE8EBBE70
volume	wds:Q81546299-79FDBA63-F3F8-40D7-8109-C8B98E58B016
issue	1
volume	6
DOI	wds:Q81546299-28153F06-3395-4285-A092-28346A9A078D
DOI	http://dx.doi.org/10.1038/SJ.TPJ.6500341
DOI	10.1038/SJ.TPJ.6500341
Dimensions Publication ID	wds:Q81546299-F22914D5-3A7A-431B-B15F-B79F0779703B
Dimensions Publication ID	1001997708
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81546299
is cites work of	Pharmacogenetics of warfarin: current status and future challenges Putting pharmacogenetics into practice Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga Prognosis research strategy (PROGRESS) 4: stratified medicine research Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine S-methyltransferase gene to evaluate risk for adverse drug events Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment Clinical use of pharmacogenomic tests in 2009 Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions Attitudes of health care professionals toward pharmacogenetic testing A review of consent practices and perspectives for pharmacogenetic testing Delivering pharmacogenetic testing in a primary care setting. Survey of US public attitudes toward pharmacogenetic testing The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require? Pharmacogenetics and the print media: what is the public told? Improved understanding of genetic and genomic influences on drug disposition and action : implications for children Role of regulatory agencies in translating pharmacogenetics to the clinics A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance Personalized medicine: new perspectives – new ethics?
is cites work of	wds:Q34022038-9125CFED-0A70-4C43-9115-BBC22ABFFFB2 wds:Q28709167-7C1F3188-007B-4C3D-83E0-6E848242C016 wds:Q31144283-4A7D4AF8-22FE-4D1E-9B17-9D9EAA1D2762

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software